In This Section

Global Scholar-in-Training Awards Recipients

Global Scholar-in-Training Awards Recipients

The American Association for Cancer Research (AACR) is proud to offer Global Scholar-in-Training Awards (GSITA) to support the career development of meritorious early-career scientists from countries building cancer research capacities. This month, the GSITA program, now in its fifth year, will bring promising scientists from 10 countries—Argentina, Brazil, China, Egypt, India, Jordan, Malawi, Nigeria, Peru, and Thailand—to participate in AACR Annual Meeting 2023 in Orlando.

Bayan Abu AlRagheb

The University of Jordan, Amman, Jordan
Abstract 3772/4: The Association of Androgen Receptor with MicroRNA Expression in Triple-Negative Breast Cancer

Ayodeji Adegoke, PhD

From Nigeria; University of the Free State, Bloemfontein, South Africa
Abstract 3829/12: Antioxidant and antiproliferative activities of Ipomoea cairica (L) extracts on three breast cancer cell lines

Anshika Chauhan

Post Graduate Institute of Medical Education and Research (PIGMER), Chandigarh, India
Abstract 2311/25: Extensive molecular heterogeneity in circulating tumor cells: A key player in oral squamous cell carcinoma prognosis

Montana Manselle Cocco

Instituto de Biologia y Medicina Experimental (CONICET), Buenos Aires City, Argentina
Abstract 1265/16: Pan-cancer study of glycosylation-related gene expression: The emerging role of galectin-2 in tumor progression

Andres Elia

Instituto de Biologia y Medicina Experimental (CONICET), Buenos Aires City, Argentina
Abstract 5289/13: Proteomic profile of breast carcinomas with unbalanced levels of progesterone receptor isoforms

Salma Fala, MD

Suez Canal University, Faculty of Medicine, Ismailia, Egypt
Abstract 4298/29: Machine learning-based model for survival prediction after ICIs in patients with solid tumors

Vidit Gaur

Indian Institute of Technology Delhi (IIT Delhi), New Delhi, India
Abstract 4128/17: AJ17 potentiates agonist CD40 antibody efficacy and attenuates agonist CD40 induced PD-L1 expression and associated toxicity in murine tumor models

Yazan Hamadneh

The University of Jordan, Amman, Jordan
Abstract 3902/21: Glutathione as a potential marker of tamoxifen resistance in breast cancer

Abram Kamiza, PhD

From Malawi; University of the Witwatersrand, Johannesburg, South Africa
Abstract 766/8: A genome-wide association study identifies the association of common variants in the major histocompatibility complex with cervical cancer in black South African women

Kelly Meza, MD

Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
Abstract 6753/13: Non-HIV cryptococcal patients with hematological malignancies: A retrospective analysis of a ten-year study from a Peruvian oncologic center

Aditi Patel

Ahmedabad University, Ahmedabad, India
Abstract 1743/8: miR-1307-5p reverses cisplatin resistance in oral squamous cell carcinomas (OSCC) by targeting EHF, a modulator of stemness genes

Agustina Sabater

Institute of Biological Chemistry of the School of Sciences (IQUIBICEN), National Scientific and Technical Research Council (CONICET), Buenos Aires City, Argentina
Abstract 2437/10: HMOX1 modulates tumor stemness and metastatic properties in prostate cancer

Juliana Siqueira, PhD

Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil
Abstract 1216/5: Virome characterization in different types of non-Hodgkin lymphoma

Kamonlapat Supimon, PhD

Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Abstract 1779/13: Fourth-generation chimeric antigen receptor T cells targeting mucin 1 against breast cancer

Jiazhang Xing

Peking Union Medical College, Beijing, China
Abstract 1983/24: Social/physical limitations and financial hardship among the US adult cancer survivors with multiple primary cancer